References
- Bonadonna G, Valagussa P. Chemotherapy of breast cancer: Current views and results. Int J Radiat Oncol Biol Phys 1983; 9: 279–297.
- Carbone PP, Tormey DC. Combination chemotherapy in advanced disease. In: McGuire WL ed., Breast cancer. Advances in research and treatment. Current approaches to therapy. New York: Plenum Pub. Corp 1977: 165.
- Donegan WL. Extended surgical adjuvant Thiotepa for mammary carcinoma. Arch Surg 1974; 109: 187–192.
- Rubens RD, Knight RK, Fentiman IS, et al. Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet 1983; 1: 839–843.
- Senn HJ. Current status and indications for adjuvant therapy in breast cancer. Cancer Chemother Pharmacol 1982; 8: 139–150.
- Wheeler TK. In: Jones SE, Salmon SE eds, Adjuvant therapy of cancer II. New York: Grune and Stratton. 1981: 371.
- Koyama H, Wada T, Takahashi Y, et al. Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer. Cancer, 1980; 46: 2373–2379.
- Cancellos GP, Pocock SJ, Taylor III SG, Sears ME, Klaessen DJ, Band PR. Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with 4 phenylalanine mustard. Cancer 1976; 38: 1882–1886.
- Mouridsen HT, Brahm TPM, Rahbek I. Evaluation of single drug versus multiple drug chemotherapy in the treatment of advanced breast cancer. Cancer Treat Rep 1977; 61: 47–50.
- Henderson IC: Adjuvant systemic therapy for early breast cancer. In: Haskell CM, ed. Current problems in cancer XI. Chicago: Year Book Med. Pubi. Inc. 1987: 129–206.
- Hryniuk W, Levine MN. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol 1986; 4: 1162–1170.
- Hibberd AD, Horwood LJ, Wells JB. Long term prognosis of women with breast cancer in New Zealand: Study of survival to 30 years: Br Med J 1983; 286: 1777–1779.
- Allan E. Breast cancer, the error of the exponential. Eur J Cancer 1978; 14: 1389–1393.